Jonathan Yuin-Han LOH

Lab Location: #8-01   Email: yhloh@imcb.a-star.edu.sg   Tel: 65869592

LOH Yuin-Han Jonathan is the Deputy Executive Director and Research Director at the A*STAR Institute of Molecular and Cell Biology (IMCB), where he also serves as the Director for the Cell Biology and Therapies Research Division. Concurrently, he is a Professor (Adj) at the National University òòò½Íø(NUS) Yong Loo Lin School of Medicine and a Faculty member of the NUS Graduate School of Integrative Sciences and Engineering. His current research focuses on dissecting the mechanisms regulating cell fate changes, including how 1) epigenetic factors work with regulatory elements to coordinate gene expression programme (2015 Cell), 2) transcription factors direct transdifferentiation and somatic cell reprogramming (2024 Nat Commun.; 2020 Science Adv.), and 3) epitranscriptome regulation of cell states (2023 Molecular Cell). His research work has earned him several prestigious national and international accolades including the MIT TR35 Asia Pacific Award, òòò½ÍøYoung Scientist Award. World Technology Network Fellowship, Stem Cell Society òòò½ÍøOutstanding Investigator Award, Entrepreneurship World Cup (with start-up Turtletree Lab) Sigma Xi Scientific Research Honor Society, National Research Foundation Investigatorship and òòò½ÍøPublic Administration Medal (Bronze). He serves as the President of Stem Cell Society òòò½Íø(SCSS), Member of the National Medical Research Council (NMRC) Open Fund Individual Research Grant committee and the Genetic Modification Advisory Committee (GMAC). Jonathan founded two biotech start-ups (InnoCellular Tech and Genovn Therapeutics) and sits on the board of directors for Nasdaq listed Cytomed Therapeutics (GDTC). 

Research
Publications